Immunotherapy Resistance Remains a Puzzle – OncLive
OncLive |
Immunotherapy Resistance Remains a Puzzle
OncLive Antoni Ribas, MD, PhD, a leading authority on immunotherapy and a Giants of Cancer Care® awardwinner, and colleagues have defined 3 types of resistance to immunotherapy that have been manifested in clinical scenarios: (1) primary resistance, in which … |
